Stay updated on Intermittent Therapy in RCC Patients: Clinical Trial
Sign up to get notified when there's something new on the Intermittent Therapy in RCC Patients: Clinical Trial page.

Latest updates to the Intermittent Therapy in RCC Patients: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.8%
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check34 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check69 days agoChange DetectedThe webpage has undergone significant updates, including the addition of the study title 'A Single-arm Phase II Trial of Intermittent Nivolumab in Patients With Metastatic Renal Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy' and the mention of 'Metastatic Renal Cell Carcinoma' as a key focus. Additionally, the revision number has been updated to v2.15.0.SummaryDifference38%
- Check84 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Intermittent Therapy in RCC Patients: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intermittent Therapy in RCC Patients: Clinical Trial page.